Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pneumonia Adults Article
This is a selection made from among articles on Drug Treatment Pneumonia Adults. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Drug Rehab or Addiction Treatment - What Is the Difference?
By Jonathan Huttner
Recently a topic of conversation centered on whether there is a difference between a drug rehab and an addiction treatment center. As surprised as people were at the question, it made all of us realize those individuals without knowledge of the addiction treatment business or who have not been in addiction treatment themselves, might be easily confused.
There really is no difference between the two as far as the terminology. When a person mentions drug rehab, they are really referring to a drug rehabilitation program, which is the same as an addiction treatment program, alcohol treatment program or chemical dependency program. All of the above are designed to treat drug addiction and alcoholism, with the only difference resting in the actual services provided, population treated and the philosophy of the program.
Differences in Addiction Treatment Services
While they all generally have residential treatment services in common, it does not mean that each has been licensed to provide detox (detoxification services), partial hospitalization or outpatient treatment. The type of services a drug rehab or addiction treatment center provides is strictly up to the owner and operator and each service must be licensed by the state where the center is located. It suffices to say that the greater the continuum of care, the more likely the center is to be able to meet the patient’s needs.
To ensure one receives quality care when joining an addiction treatment program, a person should contact a drug rehab facility accredited by JCAHO (The Joint Commission of Accreditation for Health Organizations), a standard-bearer in health-care facilities, which assures the consumer that the accredited facility has achieved and continually maintains clinical and professional practices which are superior in its specialized field of treatment.
There are numerous sites about drug rehab facilities on the web and you should evaluate their credentials carefully. RecoveryConnection.org refers people to addiction treatment centers accredited by JCAHO.
Jonathan Huttner is one of the the principals at Lakeview Health Systems, an addiction treatment,
alcohol and drug rehab facility.
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Drug-Rehab-or-Addiction-Treatment---What-Is-the-Difference?&id=350080
Drug Treatment Pneumonia Adults Specific links
Drug Treatment Pneumonia Adults News
Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of ...
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...Press Release
Sunovion Pharmaceuticals Inc. Posted on:05 May 12 Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia.
Read more...Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance ...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular depot formulation for the maintenance treatment of adults with schizophrenia.
Read more...Popular Antibiotic May Raise Risk of Sudden Death
Azithromycin may be risky for adults with heart problems, a new study finds, by possibly causing abnormal, potentially fatal, heart rhythms.
Read more...Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase ...
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .
Read more...New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology ...
Bristol-Myers Squibb Company today announced that new data on its approved and investigational oncology compounds will be featured in ten oral presentations at the 48th Annual Meeting of the American Society of Clinical Oncology in Chicago from June 1-5.
Read more...New Study Shows Patients Can Effectively be Switched to Latuda® (lurasidone HCl) from Other Antipsychotic Agents
Sunovion Pharmaceuticals Inc. today announced results from an open-label study that switched clinically stable, but symptomatic adult outpatients with schizophrenia from other antipsychotic agents to LATUDA .
Read more...Clinical trials critical to medicine, patient health, doctors say
It used to be that patients with cystic fibrosis couldn't expect to live very long, yet they are now living into their 40s.
Read more...FDA expands use for FilmArray Respiratory Panel
The U.S. Food and Drug Administration today expanded the use for the FilmArray Respiratory Panel, the first test that can simultaneously detect both viral and bacterial causes of respiratory infection from a single sample.
Read more...